Search all the public and authenticated articles in CiteULike.
Enter a search phrase. You can also specify

a CiteULike article id (123456),

a DOI (doi:10.1234/12345678)

or a PubMed Id (pmid:12345678).

Click Help for advanced usage.

CiteULike

kate3671's CiteULike

Home
News/Blog
Citegeist
Everyone's Library

Browse Groups
Search Groups
Journals

FAQ^NEW
Discussion

Library
Unread
Search
Authors
Tags
Export

Profile
Publications
Blog
Context Menu

Groups
Connections
Recommendations^NEW
Neighbours
Watchlist

kate3671's Gerich:J [1 article] Export

Recent papers posted to kate3671's library by the author Gerich:J. You can also see everyone's Gerich:J.

Hide details Show details

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. [My Copy]

Diabetes care, Vol. 26, No. 11. (November 2003), pp. 3080-3086.

by Matthew C. Riddle, Julio Rosenstock, John Gerich, Insulin Glargine 4002 Study Investigators

posted to target oral nph insulin hypoglycemia glargine diabetes combination by kate3671 on 2009-09-26 06:45:34 as read

along with 2 people and 1 group ggrassi worx11 XROWXR

Note: You may cite this page as: http://www.citeulike.org/user/kate3671/author/Gerich:J

kate3671's tags

All tags in kate3671's library

Filter:

[Display as Cloud] [Display as List]

risk	3
diabetes	3
cardiovascular	3
oral	1
combination	1
glycemic	1
controversy	1
complications	1
hypoglycemia	1
cvd	1
postprandial	1
of	1
control	1
target	1
aggressive	1
glycemia	1
nph	1
disease	1
diagnosis	1
insulin	1
glargine	1

Privacy Statement | Terms & Conditions

CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.